Jean-alain A. Fehrentz
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
LEAP2 modulates β-adrenergic triggered cardiac responses and provokes antihypertensive effects.
Journal: Life sciences
Published: November 12, 2025
Selective Coupling of Aminophosphole-Based Fluorophores to Unprotected Peptides through P-S Bond Formation.
Journal: Bioconjugate chemistry
Published: September 10, 2025
Membrane cholesterol modulates engagement of β-arrestin with the ghrelin receptor.
Journal: Communications biology
Published: August 11, 2025
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 30, 2025
Additive effect of leptin and palm-LEAP2(1-14) ameliorates obesity-induced metabolic stress in ob/ob mice.
Journal: European journal of pharmacology
Published: June 16, 2025
Simultaneous treatment with palm-LEAP2(1-14) and feeding high-fat diet attenuates liver lipid metabolism but not obesity: Sign of selective resistance to palm-LEAP2(1-14).
Journal: Molecular and cellular endocrinology
Published: August 18, 2024
Growth hormone secretagogue receptor and cannabinoid receptor type 1 intersection in the mouse brain.
Journal: Brain structure & function
Published: August 01, 2024
GHSR in a Subset of GABA Neurons Controls Food Deprivation-Induced Hyperphagia in Male Mice.
Journal: Endocrinology
Published: March 06, 2024
Last Updated: 09/26/2026